BETA

7 Amendments of Aldo PATRICIELLO related to 2014/2228(INI)

Amendment 80 #
Draft opinion
Paragraph 3 a (new)
3a. Calls on the EU and the US competent authorities to ensure regulatory convergence for the approval of medicines to avoid unnecessary duplications and to work towards single development plans, while guaranteeing EU standards;
2015/03/05
Committee: ITRE
Amendment 154 #
Draft opinion
Paragraph 6 a (new)
6a. Welcomes the high priority given by the Pharmaceutical Committee of the Commission to the objective of Mutual Recognition of GMP inspections through the establishment of the Mutual Reliance Initiative; calls for the inclusion in the TTIP of an ambitious roadmap with key milestones to deliver on this priority and to avoid any other unnecessary regulatory duplications.
2015/03/05
Committee: ITRE
Amendment 168 #
Draft opinion
Paragraph 4
4. Agrees with Commissioner Malmström that all areas where the EU and the US have very different rules or approaches should be excluded from the negotiations12 ; __________________ 12See speech by EU Trade Commissioner Cecilia Malmström of 11 December 2014.there should not be a trade-off between the economic goals and the people's health, safety and the environment; agrees further with the Commissioner that where Europe and the United States have very different rules, there will be no agreement, such as GMOs, the use of hormone in bovine sector, REACH and Cloning; __________________
2015/02/24
Committee: ENVI
Amendment 172 #
Draft opinion
Paragraph 4 a (new)
4 a. Asks for an adequate legal protection of European GIs in the US market and the end of misleading use of GIs;
2015/02/24
Committee: ENVI
Amendment 176 #
Draft opinion
Paragraph 4 b (new)
4 b. Calls for a regulatory framework on pesticides, which puts consumers safety first, enhances cooperation between authorities in the assessment procedures and methodologies for risk evaluation, and establishes a pest management cooperation in order to avoid animal and plant pests, which can cause unproportionate trade barriers;
2015/02/24
Committee: ENVI
Amendment 179 #
Draft opinion
Paragraph 4 c (new)
4 c. Underlines that the negotiations on the health and pharmaceutical sector shall deliver benefits for citizens by having access to high quality medical products and services through affordable prices, by an increased cross-border scientific knowledge and through the removal of unnecessary and burdensome approval processes and inspections; calls for a speeding up of the approval of new medicines and medical devices and the establishment of a regulatory cooperation, which creates synergies and avoids burdensome approval processes and inspections in the sector while keeping the highest quality of services and products;
2015/02/24
Committee: ENVI
Amendment 182 #
2015/02/24
Committee: ENVI